Quick Answer
HAEMONETICS CORP reported Total Assets of $2.45 billion for fiscal year 2025.
HAEMONETICS CORP Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $2.45B | +11.6% |
| 2024 | $2.20B | +13.5% |
| 2023 | $1.93B | +4.0% |
| 2022 | $1.86B | +2.2% |
| 2021 | $1.82B | +43.6% |
| 2020 | $1.27B | -0.6% |
| 2019 | $1.27B | +3.0% |
| 2018 | $1.24B | -0.1% |
| 2017 | $1.24B | -6.1% |
| 2016 | $1.32B | -11.2% |
| 2015 | $1.49B | -1.9% |
| 2014 | $1.51B | +3.6% |
| 2013 | $1.46B | +60.5% |
| 2012 | $911.13M | +9.3% |
| 2011 | $833.26M | +9.0% |
| 2010 | $764.30M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $2.49B | -1.6% | +2.0% |
| September 30, 2025 | $2.44B | -3.3% | -0.8% |
| June 30, 2025 | $2.46B | -3.1% | +0.5% |
| March 31, 2025 | $2.45B | +11.6% | -3.2% |
| December 31, 2024 | $2.53B | +15.0% | +0.2% |
| September 30, 2024 | $2.53B | +25.6% | -0.6% |
| June 30, 2024 | $2.54B | +29.5% | +15.7% |
| March 31, 2024 | $2.20B | +13.5% | -0.2% |
- HAEMONETICS CORP showed an increase of +11.6% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, HAEMONETICS CORP’s total assets has grown by 220.7% (from $764.30 million to $2.45 billion).
- The most recent figure is from HAEMONETICS CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: